Correlation of soluble triggering receptor expressed on myeloid cells-1 in cerebrospinal fluid with Alzheimer’s disease biomarkers and cognitive function in non-dementia individuals

Correlation of soluble triggering receptor expressed on myeloid cells-1 in cerebrospinal fluid with Alzheimer’s disease biomarkers and cognitive function in non-dementia individuals

Objective To investigate the correlation of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in cerebrospinal fluid (CSF) with core Alzheimer’s disease (AD) biomarkers and cognitive function in non-dementia individuals. Methods A total of 558 non-dementia individuals in the Alzheim...

Full description

Saved in:

Bibliographic Details
Main Author:	GUO Haihua, WANG Huifu
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Precision Medicine 2025-04-01
Series:	精准医学杂志
Subjects:	alzheimer disease\|cognitive dysfunction\|tauopathies\|triggering receptor expressed on myeloid cells-1\|biomarkers
Online Access:	https://jpmed.qdu.edu.cn/fileup/2096-529X/PDF/1745982292030-205580433.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tau seeding activity in the cerebrospinal fluid of Alzheimer disease patients predicts short-term cognitive decline
by: Ludivine Houzé, et al.
Published: (2025-07-01)

Role of soluble triggering receptor expressed on myeloid cells-1 and serum procalcitonin in exacerbation of chronic obstructive pulmonary disease
by: Nagwa I. Okaily, et al.
Published: (2025-01-01)

Non-mutated human tau stimulates Alzheimer’s disease-relevant neurodegeneration in a microglia-dependent manner
by: Ethan R. Roy, et al.
Published: (2025-07-01)

Cerebrospinal Fluid Biomarkers of Alzheimer Disease
by: Kseniya V. Nevzorova, et al.
Published: (2025-06-01)

Diagnostic and Predictive Values of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Sepsis: A Multi-Center Prospective Clinical Study
by: Wang K, et al.
Published: (2025-06-01)

Amylin exacerbates tau pathology in the visual cortex of diabetic mice by impairing lysosomal activity
by: Daniel Moreira-Silva, et al.
Published: (2025-09-01)

Predictive value of urinary triggering receptors expressed on myeloid cells-1 on contrast-induced nephropathy after percutaneous coronary intervention
by: Lai Dong-yan, et al.
Published: (2022-04-01)

Accuracy of the Brief Cognitive Screening Battery for diagnosing Alzheimer's disease defined by cerebrospinal fluid biomarkers and AT(N) classification: a case-control study
by: Patrícia Regina Henrique Peles, et al.
Published: (2021-11-01)

Associations of varicose veins with cerebrospinal fluid biomarkers of Alzheimer’s disease pathologies in adults without dementia: the CABLE study
by: Min Liu, et al.
Published: (2025-03-01)

Combined Ionizing Radiation Caused Cognition and Non-Cognition Behavior Benefits and Modulated Microglial Activity in Wild-Type and Alzheimer’s-like Transgenic Mice
by: Viktor S. Kokhan, et al.
Published: (2025-06-01)

Truncated tau disrupts autophagy and endolysosomal systems
by: Saskia J. Pollack, et al.
Published: (2024-12-01)

Loss of excitatory inputs and decreased tonic and evoked activity of locus coeruleus neurons in aged P301S mice
by: Anthony M. Downs, et al.
Published: (2025-05-01)

Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB
by: Vinicia A Polito, et al.
Published: (2014-07-01)

ANXA2 Protein and Its Role in Neurodegeneration Processes
by: Suzanna A. Partevian, et al.
Published: (2025-03-01)

Neurodegeneration: 2024 update
by: John F. Crary
Published: (2024-12-01)

Development of a novel radioiodinated compound for amyloid and tau deposition imaging in Alzheimer's disease and tauopathy mouse models
by: Xiyan Rui, et al.
Published: (2024-12-01)

Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
by: Jakob M Bader, et al.
Published: (2020-06-01)

Using cerebrospinal fluid biomarkers to diagnose Alzheimer’s disease: an Australian perspective
by: Dhamidhu Eratne, et al.
Published: (2024-12-01)

Association between neuroinflammation, vascular risk, and biomarkers in Alzheimer’s disease
by: CHEN Yanming, HU Heying, CUI Ruiping, HU Hao, TAN Chenchen, TAN Lan
Published: (2025-08-01)

Cerebrospinal fluid amyloid beta and tau protein: Biomarkers for Alzheimer's disease
by: Mandić Gorana, et al.
Published: (2008-01-01)

The Role of Tau in Neuronal Function and Neurodegeneration
by: Gonzalo Emiliano Aranda-Abreu, et al.
Published: (2025-05-01)

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
by: Niklas Mattsson, et al.
Published: (2016-08-01)

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
by: Sebastian Palmqvist, et al.
Published: (2019-11-01)

Cerebrospinal fluid levels of tumour necrosis factor-α and its receptors are not associated with disease progression in Alzheimer’s disease
by: Manal Aljuhani
Published: (2025-04-01)

Correlations Between Cerebrospinal Fluid Biomarkers Concentration and Severity of Cognitive Impairment in Alzheimer Disease
by: Joanna Tarasiuk, et al.
Published: (2018-06-01)

Tau and tauopathies across primate species: implications for modeling neurodegenerative disorders
by: Julia C. Colwell, et al.
Published: (2025-07-01)

Increased cerebrospinal fluid and plasma apoE glycosylation is associated with reduced levels of Alzheimer’s disease biomarkers
by: Dobrin Nedelkov, et al.
Published: (2025-07-01)

Biological markers of Alzheimer's disease in cerebrospinal fluid: clinical and laboratory comparisons
by: K. V. Shevtsova, et al.
Published: (2024-06-01)

Seeding activity of skin misfolded tau as a biomarker for tauopathies
by: Zerui Wang, et al.
Published: (2024-11-01)

Machine-learning based strategy identifies a robust protein biomarker panel for Alzheimer’s disease in cerebrospinal fluid
by: Xiaosen Hou, et al.
Published: (2025-07-01)

The predictive value of procalcitonin, C-reactive protein, presepsin, and soluble-triggering receptor expressed on myeloid cell levels in bloodstream infections in pediatric patients with febrile neutropenia
by: Zeynep Canan Özdemir, et al.
Published: (2019-06-01)

Associations between platelet indices and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact adults: the CABLE study
by: Shi-Yin Xiong, et al.
Published: (2025-05-01)

Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer’s disease patients
by: Matthew Paul Lennol, et al.
Published: (2022-11-01)

Growth‐Associated Protein 43 Levels in the Cerebrospinal Fluid Correspond to the Cerebral Blood Flow Alterations in Alzheimer's Dementia Continuum: An Original Study
by: Neda Songhori, et al.
Published: (2025-03-01)

Signaling pathways and posttranslational modifications of tau in Alzheimer’s disease: the humanization of yeast cells
by: Jürgen J. Heinisch, et al.
Published: (2016-03-01)

Priapism in chronic myeloid leukemia: Meeting at the crossroads and heading in different directions
by: Kundan Mishra, et al.
Published: (2020-01-01)

Sentinels of neuroinflammation: the crucial role of myeloid cells in the pathogenesis of gliomas and neurodegenerative diseases
by: Blanca Cómitre-Mariano, et al.
Published: (2024-11-01)

Corrigendum: Differentiation of Alzheimer's disease from other neurodegenerative disorders using chemiluminescence immunoassays measuring cerebrospinal fluid biomarkers
by: Philipp Arendt, et al.
Published: (2025-02-01)

Alcohol consumption and cerebrospinal fluid biomarkers for preclinical alzheimer’s disease in a population-based sample of 70-year-olds
by: Silke Kern, et al.
Published: (2025-07-01)

(−)‐Epicatechin Rescues Memory Deficits by Activation of Autophagy in a Mouse Model of Tauopathies
by: Yanqing Wu, et al.
Published: (2025-04-01)